Royal Research appears to have shut down. Royal Research is reported to have ceased operations during the 2025–2026 research-peptide enforcement wave. If you relied on Royal Research, here is what is known, how to vet a replacement, and the tested equivalents at Life Link Research. For licensed laboratory research use only.
What happened to Royal Research?
Royal Research is among at least eight research-peptide vendors reported offline between mid-2025 and early 2026, as FDA enforcement escalated (50+ warning letters in September 2025 and at least one warehouse raid), GLP-1 makers Eli Lilly and Novo Nordisk pursued suppliers, payment processors withdrew, and independent testing exposed quality failures. Verify Royal Research’s current status independently before transacting.
See the full sourced status list in our Research Peptide Vendor Trust Index 2026.
How to choose a replacement
Score any vendor on the 7-point checklist in the Trust Index: independent third-party COAs, batch/lot-specific testing, a full identity-purity-sterility panel, a public COA library, 12+ months operating, US stock and shipping, and transparent ownership with stable payments.
Tested equivalents at Life Link Research
Every batch is third-party tested with published COAs. For licensed laboratory research use only.
| Compound | Tested equivalent |
|---|---|
| Retatrutide / Tirzepatide / Semaglutide / Cagrisema | Browse GLP-1 peptides |
| BPC-157 / TB-500 | Browse healing peptides |
| Ipamorelin / CJC-1295 / GHK-Cu / KPV / DSIP / MT-2 | Shop all |
Switching from Royal Research? Use code SWITCH15 for 15% off your first order.
FAQ
Did Royal Research shut down?
Royal Research is reported to have ceased operations during the 2025–2026 enforcement wave; verify current status independently.
What is a trustworthy Royal Research alternative?
Any vendor that meets the 7-point checklist — independent batch COAs and a public COA library are the strongest signals. Compare options in the Trust Index.